Search Results - "Graminske, S."

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Red blood cell concentrates treated with the amustaline (S‐303) pathogen reduction system and stored for 35 days retain post‐transfusion viability: results of a two‐centre study by Cancelas, J. A., Gottschall, J. L., Rugg, N., Graminske, S., Schott, M. A., North, A., Huang, N., Mufti, N., Erickson, A., Rico, S., Corash, L.

    Published in Vox sanguinis (01-04-2017)
    “…Background and Objectives Pathogen reduction technology using amustaline (S‐303) was developed to reduce the risk of transfusion‐transmitted infection and…”
    Get full text
    Journal Article
  2. 2

    Multi-institutional randomized control study of haemolysis in stored red cell units prepared manually or by an automated system by McAteer, M. J., Dumont, L. J., Cancelas, J., Rugg, N., Vassallo, R., Whitley, P., Graminske, S., Friedman, K.

    Published in Vox sanguinis (01-07-2010)
    “…Background  The haemolysis level at the end of storage is a performance parameter for RBC preparations. In the evaluation of new devices or new processes for…”
    Get full text
    Journal Article
  3. 3
  4. 4